Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Feb-Mar;19(1):12-6.

Retention in HIV care: what the clinician needs to know

Affiliations
Review

Retention in HIV care: what the clinician needs to know

Thomas P Giordano. Top Antivir Med. 2011 Feb-Mar.

Abstract

Poor retention in HIV disease care is a common, modifiable risk factor associated with poor outcomes, including higher rates of antiretroviral therapy failure, increased HIV transmission risk behaviors, and worse survival. Predictors of poor retention include younger age, female sex, racial or ethnic minority status, low socioeconomic status, no usual source of health care, less advanced HIV disease, fewer non-HIV-related comorbidities, and greater unmet psychosocial needs. Thus far, there have been few published randomized trials of interventions to improve retention. The fact that most clinics are understaffed and underresourced in a flat funding environment raises serious questions about the translation, dissemination, and sustainability of interventions found to be successful in the research setting. Efforts to improve retention in care should incorporate informational, motivational, and behavioral skills components. Practical steps can be taken by clinics to improve retention. This article summarizes a lecture by Thomas P. Giordano, MD, MPH, at the 13th Annual Clinical Conference for the Ryan White HIV/AIDS Program held in Washington, DC, in August 2010.

PubMed Disclaimer

Conflict of interest statement

Financial Disclosure: Dr Giordano has no relevant financial affiliations to disclose.

Figures

Figure 1
Figure 1
Cumulative probability of survival according to the number of quarters with an HIV care visit during the first year after receipt of an antiretroviral therapy prescription. Based on Veterans Affairs data for patients initiating antiretroviral therapy in the late 1990s. Adapted from Giordano et al.
Figure 2
Figure 2
Examples of measuring retention in care. Top, quarterly tracking of attended appointments (checked boxes) and missed appointments (X). Bottom, various measures of the tracking results for Patients A through D. HRSA indicates Health Resources and Services Administration; HAB, HIV/AIDS Bureau. Adapted from Mugavero et al.18

Similar articles

Cited by

References

    1. Dieffenbach CW, Fauci AS. Universal voluntary testing and treatment for prevention of HIV transmission. JAMA. 2009;301:2380-2382. - PubMed
    1. Bozzette SA, Berry SH, Duan N, et al. The care of HIV-infected adults in the United States. N Engl J Med. 1998;339:1897-1904. - PubMed
    1. Fleming PL, Byers RH, Sweeney PA, Daniels D, Karon JM, Janssen RS. HIV prevalence in the United States, 2000. [Abstract 11.] 9th Conference on Retroviruses and Opportunistic Infections (CROI) February 24-28, 2002; Seattle, WA.
    1. Recsky MA, Brumme ZL, Chan KJ, et al. Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy. J Infect Dis. 2004;190:285292. - PubMed
    1. Gardner LI, Metsch LR, Anderson-Mahoney P, et al. Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS. 2005;19:423-431. - PubMed

LinkOut - more resources